Journal article

Long-term benefit of probiotic peanut oral immunotherapy on quality of life in a randomized trial

A Dunn Galvin, M Lloyd, KC Hsiao, MLK Tang

Journal of Allergy and Clinical Immunology in Practice | Published : 2021

University of Melbourne Researchers

Grants

Awarded by Food Allergy and Anaphylaxis Network


Funding Acknowledgements

The parent trial was supported by the Food Allergy and Anaphylaxis Network (FAAN), the Murdoch Children's Research Institute, Perpetual Philanthropy (grant ID 493), the Cass Foundation, the Financial Markets Foundation for Children, and the National Health and Medical Research Council Australia (NHMRC project grant no. 1029690). The 4-year follow-up was supported by the Murdoch Children's Research Institute and the Australian Food Allergy Foundation. Nestle Health Science provided the probiotic and placebo treatments. The Murdoch Children's Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program. This trial was registered with the Australian New Zealand Clinical Trials Registry (ACTRN12608000594325, November 25, 2008).